{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:15:56Z","timestamp":1785575756450,"version":"3.56.0"},"reference-count":38,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1722,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1111\/j.1365-2222.2010.03648.x","type":"journal-article","created":{"date-parts":[[2010,12,14]],"date-time":"2010-12-14T11:26:19Z","timestamp":1292325979000},"page":"96-103","source":"Crossref","is-referenced-by-count":51,"title":["Assessing potential determinants of positive provocation tests in subjects with NSAID hypersensitivity"],"prefix":"10.1111","volume":"41","author":[{"given":"M.","family":"Viola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Rumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. L.","family":"Valluzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Gaeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,12,14]]},"reference":[{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/B978-0-323-05659-5.00069-3","volume-title":"Middleton's allergy. Principles & practice","author":"Szczeklik","year":"2009"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1081-1206(10)60615-1","article-title":"Pathogenesis, diagnosis, and treatment of aspirin intolerance","volume":"99","author":"Jenneck","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1081-1206(10)62221-1","article-title":"Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes","volume":"87","author":"Stevenson","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1398-9995.1981.tb01842.x","article-title":"Idiosyncrasy to pyrazolone drugs","volume":"36","author":"Czerniawska-Mysik","year":"1981","journal-title":"Allergy"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1067\/mai.2003.163","article-title":"IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone","volume":"111","author":"Himly","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/ACI.0b013e32832db943","article-title":"Selective immediate hypersensitivity reactions to NSAIDs","volume":"9","author":"Canto","year":"2009","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB7|cit7","first-page":"355","article-title":"Nonsteroidal anti-inflammatory drug hypersensitivity syndrome. A multicenter study. I. Clinical findings and in vitro diagnosis","volume":"19","author":"De Weck","year":"2009","journal-title":"J Invest Allergol Clin Immunol"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1067\/mai.2001.113241","article-title":"Selective severe anaphylactic reaction due to ketorolac tromethamine without nonsteroidal anti-inflammatory drug intolerance","volume":"107","author":"Scala","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1034\/j.1398-9995.2000.00562.x","article-title":"Selective hypersensitivity to diclofenac","volume":"55","author":"Del Pozo","year":"2000","journal-title":"Allergy"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S1081-1206(10)62580-X","article-title":"Paracetamol (acetaminophen) hypersensitivity","volume":"85","author":"De Paramo","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jaci.2006.07.024","article-title":"Clinical and pathologic perspectives on aspirin sensitivity and asthma","volume":"118","author":"Stevenson","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB12|cit12","first-page":"771","article-title":"Hypersensitivity to aspirin","volume":"113","author":"Mastalerz","year":"2004","journal-title":"common eicosanoid alterations in urticaria and asthma"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB13|cit13","first-page":"854","article-title":"European Network for Drug Allergy (ENDA); EAACI interest group on drug hypersensitivity. Drug provocation testing in the diagnosis of drug hypersensitivity reactions","volume":"58","author":"Aberer","year":"2003","journal-title":"general considerations"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.7326\/0003-4819-140-12-200406150-00009","article-title":"Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction","volume":"140","author":"Messaad","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB15|cit15","first-page":"1111","article-title":"EAACI\/GA2LEN guideline","volume":"62","author":"Ni\u017aankowska-Mogilnicka","year":"2007","journal-title":"aspirin provocation tests for diagnosis of aspirin hypersensitivity"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2222.2008.03155.x","article-title":"BSACI guidelines for the management of drug allergy","volume":"39","author":"Mirakian","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000236999","article-title":"Oral provocation test in the diagnosis of anaphylactoid reactions to \u2018mild\u2019 analgesic preparations","volume":"107","author":"Vieluf","year":"1995","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB18|cit18","first-page":"678","article-title":"Intolerance to nonsteroidal anti-inflammatory drugs","volume":"98","author":"Quiralte","year":"1996","journal-title":"results of controlled drug challenges in 98 patients"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB19|cit19","first-page":"1366","article-title":"The accuracy of the diagnosis of suspected paracetamol (acetaminophen) hypersensitivity","volume":"32","author":"Kvedariene","year":"2002","journal-title":"results of a single-blinded trial"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB20|cit20","first-page":"491","article-title":"Oral challenge in patients with suspected cutaneous adverse drug reactions","volume":"85","author":"Lammintausta","year":"2005","journal-title":"findings in 784 patients during a 25-year-period"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB21|cit21","first-page":"164","article-title":"Nonsteroidal anti-inflammatory drug hypersensitivity","volume":"15","author":"Schubert","year":"2005","journal-title":"fable or reality?"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB22|cit22","first-page":"561","article-title":"Hypersensitivity to cyclooxygenase inhibitory drugs in children","volume":"18","author":"Hassani","year":"2008","journal-title":"a study of 164 cases"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1081-1206(10)60465-6","article-title":"Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis","volume":"100","author":"Dursun","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jaci.2008.09.048","article-title":"Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease","volume":"123","author":"Hope","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1034\/j.1399-3003.2000.016003432.x","article-title":"Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma","volume":"16","author":"Szczeklik","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1081-1206(10)62084-4","article-title":"The natural history and clinical characteristics of aspirin-exacerbated respiratory disease","volume":"89","author":"Berges-Gimeno","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1081-1206(10)62748-2","article-title":"Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity","volume":"84","author":"S\u00e1nchez-Borges","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000098658","article-title":"Etoricoxib tolerability in patients with hypersensitivity to nonsteroidal anti-inflammatory drugs","volume":"143","author":"Viola","year":"2007","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/j.1365-2222.2005.02317.x","article-title":"Diagnosing immediate reactions to cephalosporins","volume":"35","author":"Romano","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB30|cit30","first-page":"665","article-title":"Executive summary of disease management of drug hypersensitivity","volume":"83","year":"1999","journal-title":"a practice parameter. Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma and Immunology, the American Academy of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0140-6736(77)91953-5","article-title":"Incidence and severity of anaphylactoid reactions to colloid volume substitutes","volume":"1","author":"Ring","year":"1977","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0140-6736(88)92975-3","article-title":"New category of drug allergy [Letter]","volume":"2","author":"Patriarca","year":"1988","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB33|cit33","first-page":"347","article-title":"Diagnosis of pyrazolone drug sensitivity","volume":"20","author":"Kowalski","year":"1999","journal-title":"clinical history versus skin testing and in vitro testing"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2222.2005.2228.x","article-title":"Oral aspirin challenges in patients with a history of intolerance to single non-steroidal anti-inflammatory drugs","volume":"35","author":"Asero","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJM200108093450607","article-title":"The coxibs, selective inhibitors of cyclooxygenase-2","volume":"345","author":"FitzGerald","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1001\/archderm.139.12.1577","article-title":"Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs","volume":"139","author":"Zembowicz","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2222.2010.03648.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1034\/j.1399-3003.2000.15e09.x","article-title":"Oral and bronchial provocation tests with aspirin for diagnosing of aspirin-induced asthma","volume":"15","author":"Ni\u017aankowska","year":"2000","journal-title":"Eur Respir J"},{"issue":"(S","key":"10.1111\/j.1365-2222.2010.03648.x-BIB38|cit38","first-page":"S776","article-title":"The primary and secondary prevention of coronary artery disease","volume":"133","author":"Becker","year":"2008","journal-title":"American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2222.2010.03648.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2222.2010.03648.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T07:17:28Z","timestamp":1625469448000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2222.2010.03648.x"}},"subtitle":["Risk factors for a positive NSAID provocation test"],"short-title":[],"issued":{"date-parts":[[2010,12,14]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2222.2010.03648.x","relation":{},"ISSN":["0954-7894"],"issn-type":[{"value":"0954-7894","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12,14]]}}}